Literature DB >> 6240280

Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets.

A P Bautista, P W Buckler, H M Towler, A A Dawson, B Bennett.   

Abstract

The use of 111Indium oxine as a platelet label for the performance of platelet life-span studies has been examined. Platelet life-span in normal subjects varied between 8 X 10 and 10 X 36 d. Patients with primary thrombocythaemia had clearly reduced platelet life-span whether or not they presented with vascular occlusion and this abnormality persisted after reduction of the platelet count to normal by busulphan therapy. Patients with similarly elevate platelet counts due to chronic granulocytic leukaemia or after splenectomy had platelet life-span values in the normal range. Plasma beta-TG levels could not be used to predict platelet life-span in these groups of patients. Measurement of platelet life-span using 111Indium labelled platelets is a useful technique in the examination of platelet function in occlusive vascular disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6240280     DOI: 10.1111/j.1365-2141.1984.tb06115.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

Review 1.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

2.  Celecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation.

Authors:  Mark Ruzov; Gilad Rimon; Oleg Pikovsky; David Stepensky
Journal:  Br J Clin Pharmacol       Date:  2015-12-15       Impact factor: 4.335

3.  Tazobactam and piperacillin-induced thrombocytopenia: A case report.

Authors:  Hong Chen; Zhen Fan; Fei Guo; Yumin Yang; Jie Li; Jie Zhang; Yudan Wang; Jianwei LE; Zhiyu Wang; Jianhua Zhu
Journal:  Exp Ther Med       Date:  2016-02-09       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.